2023 could be pivotal in the U.S. healthcare industry as major IDNs and payers compete over control of the patient journey.
Watch this recording to hear our experts with deep knowledge on U.S. regulatory trends and the market access landscape discuss recent developments and predictions for the next decade.
Takeaways from this panel include: